Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

ClinicalTrials.gov ID: NCT00605176

Public ClinicalTrials.gov record NCT00605176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Four Weeks of Treatment With Imiquimod Creams for Actinic Keratoses

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether imiquimod creams are effective in treating Actinic Keratoses when applied to the face or balding scalp. Actinic keratosis (AK) is a skin condition that shows up on skin routinely exposed to the sun, such as the face, scalp, shoulders, chest, back, arms, and hands. The active ingredient contained in the study cream for this study is the same as that of the approved product Aldara, which has been shown to be safe and effective for the treatment of AKs.

Study identification

NCT ID
NCT00605176
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Graceway Pharmaceuticals, LLC
Industry
Enrollment
479 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Jun 30, 2008
Completion
Jun 30, 2008
Last update posted
Jun 28, 2010

2008

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Not listed Fremont California 94538
Not listed Los Angeles California 90045
Not listed Riverside California 92506
Not listed San Diego California 92117
Not listed Vallejo California 94589
Not listed Miami Florida 33144
Not listed Newnan Georgia 30263
Not listed Boise Idaho 83704
Not listed Springfield Illinois 62703
Not listed Dubuque Iowa 52002
Not listed Olathe Kansas 66061
Not listed Wichita Kansas 67206
Not listed Marrero Louisiana 70072
Not listed Henderson Nevada 89052
Not listed Rochester New York 14623
Not listed High Point North Carolina 27262
Not listed Winston-Salem North Carolina 27106
Not listed Portland Oregon 97239
Not listed Nashville Tennessee 37215
Not listed Austin Texas 78759
Not listed Dallas Texas 75230
Not listed Houston Texas 77056
Not listed San Antonio Texas 78229
Not listed Salt Lake City Utah 84124
Not listed West Jordan Utah 84088
Not listed Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00605176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2010 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00605176 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →